Skip to main content

Table 1 Constraints for organs at risk (OARs) in the phase II study on radio-thermotherapy for biochemical recurrent prostate cancer

From: Regional hyperthermia and moderately dose-escalated salvage radiotherapy for recurrent prostate cancer. Protocol of a phase II trial

Organs at risk (OARs)

Constraints

 

V50

V60

V65

V70

Rectal wall

n.a.

≤50%

n.a.

≤20%

Bladder wall

n.a.

n.a.

≤50%

n.a.

Femoral heads

≤10%

n.a.

n.a.

n.a.

  1. n.a. not applicable, OAR organs at risk, V organ volume receiving a specified dose